SAN DIEGO, July 2, 2024 /PRNewswire/ -- NanoCellect Biomedical, a leader in microfluidic cell sorting technology, proudly announces the launch of VERLO™ Image-Guided Cell Sorter, a groundbreaking cell ...
NanoCellect Biomedical announced new NIH funding and technical advances on their WOLFTM Cell Sorter. NanoCellect has the goal of making the “coin star” for cell biologists. “Instead of pennies and ...
NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies for cell based assays. Our microfluidic flow cytometry platforms ...
San Diego start-up NanoCellect Biomedical, which has developed technology that acts like a Coinstar machine for sorting cells, has raised $10 million in venture capital funding. The funding round was ...
SAN DIEGO, July 25, 2019 /PRNewswire/ -- NanoCellect Biomedical, Inc., a leader in the development and manufacturing of modern and simple solutions for cell based assays, today announced that is has ...
WATERTOWN, Mass., June 17, 2022 /PRNewswire/ -- Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical ...
SAN DIEGO, Nov. 29, 2017 /PRNewswire/ -- NanoCellect Biomedical Inc., a developer of microfluidic cell sorting technologies for cell-based assays, today announced the completion of a $10 million ...
San Diego biotech NanoCellect Biomedical raised $10 million in a Series B round, led by investment from Illumina Ventures. NanoCellect’s cell sorting and analysis technology has wide-ranging ...
SAN DIEGO, Calif., July 24, 2019 /PRNewswire/ -- NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced ...
NanoCellect Biomedical announced new NIH funding and technical advances on their WOLFTM Cell Sorter. NanoCellect has the goal of making the “coin star” for cell biologists. “Instead of pennies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results